Sarda Proteins Ltd. announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company announced net sales/income from operations of INR 15.952 million compared to INR 6.359 million a year ago. Loss from ordinary activities before finance costs and exceptional items of INR 0.919 million compared to INR 1.232 million a year ago. Loss from ordinary activities before tax was INR 0.937 million compared to INR 1.256 million a year ago. Net loss for the period was INR 0.937 million or INR 0.54 per basic and diluted share before and after extraordinary items compared to loss of INR 1.256 million or INR 0.73 per basic and diluted share before and after extraordinary items a year ago. For the nine months, the company announced net sales/income from operations of INR 39.321 million compared to INR 17.817 million a year ago. Loss from ordinary activities before finance costs and exceptional items of INR 1.573 million compared to INR 1.857 million a year ago. Loss from ordinary activities before tax was INR 1.694 million compared to INR 1.955 million a year ago. Net loss for the period was INR 1.694 million or INR 0.98 per basic and diluted share before and after extraordinary items compared to INR 1.839 million or INR 1.07 per basic and diluted share before and after extraordinary items a year ago.